Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL10432095 | 0.89 | CA12 (0.46) | TSHRALDH1A1KIF11CES1 | |
| SCHEMBL776744 | 0.80 | ALDH1A1 (0.35) | TSHRALDH1A1KIF11 | |
| SCHEMBL775529 | 0.80 | ALDH1A1 (0.35) | TSHRALDH1A1KIF11 | |
| SCHEMBL7929166 | 0.77 | CA1 (0.32) | — | |
| SCHEMBL13703265 | 0.77 | NR1H2 (0.31) | — | |
| SCHEMBL775604 | 0.77 | NR1H2 (0.32) | TSHRALDH1A1 | |
| SCHEMBL11659804 | 0.76 | TSHR (0.33) | TSHRALDH1A1 | |
| SCHEMBL7651489 | 0.75 | LMNA (0.38) | TSHRALDH1A1 | |
| SCHEMBL17288700 | 0.75 | — | — | |
| SCHEMBL7940657 | 0.75 | ESR1 (0.39) | TSHRALDH1A1KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250242340-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) | 2025-07-31 | — | — | US | claimed |
| US-20250163014-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-22 | — | — | US | claimed |
| EP-4504404-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2025-02-12 | — | — | EP | claimed |
| EP-4491621-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-01-15 | — | — | EP | claimed |
| CN-119300914-A | SABRE catalysts containing fluorinated carbon chains for delivery of metal-free MRI contrast agents | 美国卫生和人力服务部 | 2025-01-10 | — | — | CN | claimed |
| CN-118829634-A | Method for producing episulfide compound | 三菱瓦斯化学株式会社 | 2024-10-22 | — | — | CN | claimed |
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-04 | — | — | US | claimed |
| WO-2023196594-A2 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-10-12 | — | — | WO | claimed |
| US-7087789-B2 | Methods for nucleophilic fluoromethylation | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2006-08-08 | — | — | US | claimed |
| US-20040230079-A1 | Methods for nucleophilic fluoromethylation | SOUTHERN CALIFORNIA, UNIVERSITY OF | 2004-11-18 | — | — | US | claimed |
| WO-2004063129-A2 | METHODS FOR NUCLEOPHILIC FLUOROMETHYLATION | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2004-07-29 | — | — | WO | claimed |
| US-6215021-B1 | TRIFLUOROMETHYL DIPHENYLSULFONIUM TRIFLATE DERIVATIVES | IDAHO RESEARCH FOUNDATION, INC. | 2001-04-10 | — | — | US | claimed |
| US-4659720-A | POULTRY ANTIPROTOZOA AGENT | MERCK & CO., INC. (US) | 1987-04-21 | — | — | US | claimed |
| EP-0113570-B1 | 5-(AMINO OR SUBSTITUTED AMINO) IMIDAZOLES | MERCK & CO. INC. (US) | 1987-02-25 | — | — | EP | claimed |
| US-4622330-A | Antiprotozoal 3-amino or substituted amino pyrazoles | MERCK & CO., INC. (US) | 1986-11-11 | — | — | US | claimed |
| EP-0113570-A1 | 5-(Amino or substituted amino) imidazoles | MERCK & CO. INC. (US) | 1984-07-18 | — | — | EP | claimed |
| US-20250242340-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250244419-A1 | INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) | 2025-07-31 | — | — | US | disclosed |
| US-4622330-A | Antiprotozoal 3-amino or substituted amino pyrazoles | MERCK & CO., INC. (US) | 1986-11-11 | — | — | US | disclosed |
| EP-0113570-A1 | 5-(Amino or substituted amino) imidazoles | MERCK & CO. INC. (US) | 1984-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250244419-A1 | INFUSION DEVICE FOR THE PREPARATION AND DELIVERY OF MRI PROBES | MPI, HAMP, HIF1A | TSHR 1785/4885ALDH1A1 3474/4885KIF11 1430/4885 |
| US-20040230079-A1 | Methods for nucleophilic fluoromethylation | PHF2, HAO2, GSTM2 | TSHR 2421/4885ALDH1A1 1240/4885KIF11 4359/4885 |
| US-20240216900-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | FABP7, FFAR1, FABP1 | TSHR 112/4885ALDH1A1 4484/4885KIF11 1187/4885 |
| US-20250242340-A1 | SABRE CATALYSTS CONTAINING FLUORINATED CARBON CHAINS FOR DELIVERY OF METAL-FREE MRI CONTRAST AGENTS | FABP7, FFAR1, FABP1 | TSHR 112/4885ALDH1A1 4484/4885KIF11 1187/4885 |
| US-20250163014-A1 | PRODUCTION METHOD FOR EPISULFIDE COMPOUND | SULT1E1, ESR2, MRPL21 | TSHR 2688/4885ALDH1A1 2081/4885KIF11 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.